FOLH1 and prostate cancer: In two phase II/III multicenter studies, [18F]F-DCFPyL and [68 Ga]Ga-PSMA-11 PET/CT demonstrated high specificity (≥ 95%) for detection of pelvic lymph node metastases in individuals with intermediate or high-risk prostate cancer undergoing radical prostatectomy [27, 28].